IGF-1 as a Potential Therapy for Spinocerebellar Ataxia Type 3
Open Access
- 21 February 2022
- journal article
- research article
- Published by MDPI AG in Biomedicines
- Vol. 10 (2) , 505
Abstract
Although the effects of growth hormone (GH) therapy on spinocerebellar ataxia type 3 (SCA3) have been examined in transgenic SCA3 mice, it still poses a nonnegligible risk of cancer when used for a long term. This study investigated the efficacy of IGF-1, a downstream mediator of GH, in vivo for SCA3 treatment. IGF-1 (50 mg/kg) or saline, once a week, was intraperitoneally injected to SCA3 84Q transgenic mice harboring a human ATXN3 gene with a pathogenic expanded 84 cytosine–adenine–guanine (CAG) repeat motif at 9 months of age. Compared with the control mice harboring a 15 CAG repeat motif, the SCA3 84Q mice treated with IGF-1 for 9 months exhibited the improvement only in locomotor function and minimized degeneration of the cerebellar cortex as indicated by the survival of more Purkinje cells with a more favorable mitochondrial function along with a decrease in oxidative stress caused by DNA damage. These findings could be attributable to the inhibition of mitochondrial fission, resulting in mitochondrial fusion, and decreased immunofluorescence staining in aggresome formation and ataxin-3 mutant protein levels, possibly through the enhancement of autophagy. The findings of this study show the therapeutic potential effect of IGF-1 injection for SCA3 to prevent the exacerbation of disease progress.Keywords
Funding Information
- Ministry of Science and Technology, Taiwan (MOST 107-2314-B-371-001-MY2)
- Changhua Christian Hospital (108-CCH-MST-156 and 109-CCH-MST-166)
This publication has 75 references indexed in Scilit:
- Sodium Valproate Alleviates Neurodegeneration in SCA3/MJD via Suppressing Apoptosis and Rescuing the Hypoacetylation Levels of Histone H3 and H4PLOS ONE, 2013
- Mouse Models of Spinocerebellar Ataxia Type 3 (Machado-Joseph Disease)Neurotherapeutics, 2012
- Mutant huntingtin's interaction with mitochondrial protein Drp1 impairs mitochondrial biogenesis and causes defective axonal transport and synaptic degeneration in Huntington's diseaseHuman Molecular Genetics, 2011
- The Machado–Joseph disease-associated mutant form of ataxin-3 regulates parkin ubiquitination and stabilityHuman Molecular Genetics, 2010
- Local insulin-like growth factor I expression is essential for Purkinje neuron survival at birthCell Death & Differentiation, 2010
- Mitochondrial and Cell Death Mechanisms in Neurodegenerative DiseasesPharmaceuticals, 2010
- Overexpression of IGF-1 in Muscle Attenuates Disease in a Mouse Model of Spinal and Bulbar Muscular AtrophyNeuron, 2009
- The Deubiquitinating Enzyme Ataxin-3, a Polyglutamine Disease Protein, Edits Lys63 Linkages in Mixed Linkage Ubiquitin ChainsJournal of Biological Chemistry, 2008
- Insulin‐like growth factor‐I (IGF‐I) inhibits neuronal apoptosis in the developing cerebral cortex in vivoInternational Journal of Developmental Neuroscience, 2007
- Growth hormone as an early embryonic growth and differentiation factorBrain Structure and Function, 2004